166 related articles for article (PubMed ID: 35450458)
1. Economic analysis of n-butyl cyanoacrylate compared with ethylene vinyl alcohol copolymer liquid embolic embolization of brain arteriovenous malformations (bAVMs) from a US hospital perspective.
Satti SR; Kottenmeier E; Khaled A; Wright GWJ; Cameron HL
Interv Neuroradiol; 2023 Aug; 29(4):434-441. PubMed ID: 35450458
[TBL] [Abstract][Full Text] [Related]
2. Use of the Apollo detachable-tip microcatheter for endovascular embolization of arteriovenous malformations and arteriovenous fistulas.
Flores BC; See AP; Weiner GM; Jankowitz BT; Ducruet AF; Albuquerque FC
J Neurosurg; 2018 Mar; 130(3):963-971. PubMed ID: 29570006
[TBL] [Abstract][Full Text] [Related]
3. Comparative cost analysis of liquid embolization systems for brain arteriovenous malformation using a real-world US hospital database: TRUFILL
Satti SR; Fan X; Kottenmeier E; Khanna R; Rai AT
Interv Neuroradiol; 2023 Dec; 29(6):696-701. PubMed ID: 35611508
[TBL] [Abstract][Full Text] [Related]
4. Effect of liquid embolic agents on Gamma Knife surgery dosimetry for arteriovenous malformations. Clinical article.
Mamalui-Hunter M; Jiang T; Rich KM; Derdeyn CP; Drzymala RE
J Neurosurg; 2011 Aug; 115(2):364-70. PubMed ID: 21495824
[TBL] [Abstract][Full Text] [Related]
5. ONYX versus n-BCA for embolization of cranial dural arteriovenous fistulas.
Rabinov JD; Yoo AJ; Ogilvy CS; Carter BS; Hirsch JA
J Neurointerv Surg; 2013 Jul; 5(4):306-10. PubMed ID: 22550096
[TBL] [Abstract][Full Text] [Related]
6. Neurological outcomes and cure rates of embolization of brain arteriovenous malformations with n-butyl cyanoacrylate or Onyx: a meta-analysis.
Elsenousi A; Aletich VA; Alaraj A
J Neurointerv Surg; 2016 Mar; 8(3):265-72. PubMed ID: 25540177
[TBL] [Abstract][Full Text] [Related]
7. Combined therapy of cerebral arteriovenous malformations: histological differences between a non-adhesive liquid embolic agent and n-butyl 2-cyanoacrylate (NBCA).
Duffner F; Ritz R; Bornemann A; Freudenstein D; Wiendl H; Siekmann R
Clin Neuropathol; 2002; 21(1):13-7. PubMed ID: 11846039
[TBL] [Abstract][Full Text] [Related]
8. Results of Endovascular-First Approach for Treatment of Scalp Arteriovenous Malformations and the Effect of Simplified Angiographic Classification in Therapeutic Decision-Making and Outcomes.
Gopinath M; Malik V; Sankara Sarma P; Rajan JE; Kannath SK
World Neurosurg; 2019 Jan; 121():e277-e286. PubMed ID: 30261380
[TBL] [Abstract][Full Text] [Related]
9. Complication risk of endovascular embolization for cerebral arteriovenous malformation.
Lv X; Wu Z; Jiang C; Li Y; Yang X; Zhang Y; Zhang N
Eur J Radiol; 2011 Dec; 80(3):776-9. PubMed ID: 20950972
[TBL] [Abstract][Full Text] [Related]
10. Safety and Effectiveness of Ethylene Vinyl Alcohol Copolymer Embolization of Peripheral High-Flow Arteriovenous Malformations: Results of a Prospective Study.
Brill RM; Guntau M; Wildgruber M; Brill E; Stangl F; Taute BM; Ukkat J; Goldann C; Wohlgemuth WA
J Vasc Interv Radiol; 2021 Dec; 32(12):1644-1653.e1. PubMed ID: 34563700
[TBL] [Abstract][Full Text] [Related]
11. N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations: results of a prospective, randomized, multi-center trial.
n-BCA Trail Investigators
AJNR Am J Neuroradiol; 2002 May; 23(5):748-55. PubMed ID: 12006271
[TBL] [Abstract][Full Text] [Related]
12. Nidal embolization of brain arteriovenous malformations using Onyx in 94 patients.
Mounayer C; Hammami N; Piotin M; Spelle L; Benndorf G; Kessler I; Moret J
AJNR Am J Neuroradiol; 2007 Mar; 28(3):518-23. PubMed ID: 17353327
[TBL] [Abstract][Full Text] [Related]
13. Nidal embolization of brain arteriovenous malformations: rates of cure, partial embolization, and clinical outcome.
Sahlein DH; Mora P; Becske T; Nelson PK
J Neurosurg; 2012 Jul; 117(1):65-77. PubMed ID: 22540403
[TBL] [Abstract][Full Text] [Related]
14. Injection of N‑butyl Cyanoacrylate Through a Dual-Lumen Balloon for Embolization of High-flow Intranidal Fistulas in Brain Arteriovenous Malformations: Technical Note.
Shotar E; Al Raaisi A; Lenck S; Premat K; Degos V; Mathon B; Clarençon F; Sourour NA
Clin Neuroradiol; 2020 Jun; 30(2):313-319. PubMed ID: 30972426
[TBL] [Abstract][Full Text] [Related]
15. Embolic Agents and Microcatheters for Endovascular Treatment of Cerebral Arteriovenous Malformations.
Triano MJ; Lara-Reyna J; Schupper AJ; Yaeger KA
World Neurosurg; 2020 Sep; 141():383-388. PubMed ID: 32592963
[TBL] [Abstract][Full Text] [Related]
16. Hemorrhage risk after partial endovascular NBCA and ONYX embolization for brain arteriovenous malformation.
Lv X; Wu Z; Li Y; Yang X; Jiang C
Neurol Res; 2012 Jul; 34(6):552-6. PubMed ID: 22663933
[TBL] [Abstract][Full Text] [Related]
17. Extending Endovascular Embolization to Type A Spinal Perimedullary Arteriovenous Fistula Using Liquid Embolic Agent: Technical Nuances, Challenges and Initial Outcome.
Malik V; Kannath SK; Rajan JE; Lukas J
World Neurosurg; 2018 Nov; 119():267-273. PubMed ID: 30118864
[TBL] [Abstract][Full Text] [Related]
18. A prospective, multicenter, randomized trial of the Onyx liquid embolic system and N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations. Clinical article.
Loh Y; Duckwiler GR;
J Neurosurg; 2010 Oct; 113(4):733-41. PubMed ID: 20433277
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic radiosurgery for arteriovenous malformations after Onyx embolization: a case-control study.
Lee CC; Chen CJ; Ball B; Schlesinger D; Xu Z; Yen CP; Sheehan J
J Neurosurg; 2015 Jul; 123(1):126-35. PubMed ID: 25658780
[TBL] [Abstract][Full Text] [Related]
20. Arteriovenous malformation in the brain: a theoretical study explaining the behavior of liquid embolic agents during endovascular treatment.
Lv X; Wu Z; Li Y
Neuroradiol J; 2013 Dec; 26(6):661-8. PubMed ID: 24355185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
